These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22919660)

  • 1. Natural killer cells in experimental and human leishmaniasis.
    Bogdan C
    Front Cell Infect Microbiol; 2012; 2():69. PubMed ID: 22919660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.
    Prajeeth CK; Haeberlein S; Sebald H; Schleicher U; Bogdan C
    Infect Immun; 2011 Jul; 79(7):2699-708. PubMed ID: 21518784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
    Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
    Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to
    Messlinger H; Sebald H; Heger L; Dudziak D; Bogdan C; Schleicher U
    Front Immunol; 2018; 9():24. PubMed ID: 29472914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection.
    Sanabria MX; Vargas-Inchaustegui DA; Xin L; Soong L
    Infect Immun; 2008 Nov; 76(11):5100-9. PubMed ID: 18794295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes.
    Lieke T; Nylén S; Eidsmo L; Schmetz C; Berg L; Akuffo H
    Parasitology; 2011 Dec; 138(14):1898-909. PubMed ID: 21902868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer activity in experimental cutaneous leishmaniasis.
    Merino F; Cruz I
    Int Arch Allergy Appl Immunol; 1984; 73(4):347-51. PubMed ID: 6698626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma.
    Nylén S; Maasho K; Söderstrom K; Ilg T; Akuffo H
    Clin Exp Immunol; 2003 Mar; 131(3):457-67. PubMed ID: 12605699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.
    Akuffo H; Maasho K; Howe R
    Clin Exp Immunol; 1993 Dec; 94(3):516-21. PubMed ID: 7902789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the role of natural killer cells in leishmaniasis.
    Alizadeh Z; Omidnia P; Altalbawy FMA; Gabr GA; Obaid RF; Rostami N; Aslani S; Heidari A; Mohammadi H
    Int Immunopharmacol; 2023 Jan; 114():109596. PubMed ID: 36700775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.
    Lieke T; Nylén S; Eidsmo L; McMaster WR; Mohammadi AM; Khamesipour A; Berg L; Akuffo H
    Clin Exp Immunol; 2008 Aug; 153(2):221-30. PubMed ID: 18713141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
    Scharton TM; Scott P
    J Exp Med; 1993 Aug; 178(2):567-77. PubMed ID: 8101861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.
    Maasho K; Sanchez F; Schurr E; Hailu A; Akuffo H
    Infect Immun; 1998 Jun; 66(6):2698-704. PubMed ID: 9596736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
    Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
    Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
    J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism.
    Bogdan C
    Cytokine X; 2020 Dec; 2(4):100041. PubMed ID: 33604563
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.
    Haeberlein S; Sebald H; Bogdan C; Schleicher U
    Eur J Immunol; 2010 Jun; 40(6):1708-17. PubMed ID: 20213736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8
    Covre LP; Devine OP; Garcia de Moura R; Vukmanovic-Stejic M; Dietze R; Ribeiro-Rodrigues R; Guedes HLM; Lubiana Zanotti R; Falqueto A; Akbar AN; Gomes DCO
    Immunology; 2020 Apr; 159(4):429-440. PubMed ID: 31925782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.